Use of Morphine Gel Topically in Patients With Stage 2-3 Wounds

Withdrawn before enrolling · Not applicable

Conditions studied: Wounds

In brief

Morphine gel applied topically to wounds will reduce wound pain and decrease patients use of oral and intravenous pain medications, therefore reducing side effects.

Key facts

Study ID

NCT00755989

Run by

Banner Health

People needed

0

Starts

2009-04-01

Expected to finish

2010-04-01

Last updated by the study team

2025-07-20

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed and dated consent form \& HIPAA
• >/= 18 yo
• Single stage 2-3 wound evaluated by our wound care team
• Alert and oriented (thinking ability clear and intact, physician approval)
• English language proficiency, likely to be able to participate in all scheduled evaluations

You may not qualify if…

• Allergy to morphine, codeine, or versa base
• pts taking medications for acute condition, other than for the wound pain (can be taking chronic pain meds if current dose stable for past 3 mo)
• Patients with neuropathies
• Patients with respiratory conditions
• Patients that are pregnant

Where it is running

• Banner Good Samaritan Medical Center — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.